Average time to pricing (years) for hemophilia brands in Italy
The ATMP Roctavian was priced in Italy roughly 1.4 years after approval. Of those hemophilia products launched in Italy, 24% see time to pricing occur between 1-2 years after approval.
The ATMP Roctavian was priced in Italy roughly 1.4 years after approval. Of those hemophilia products launched in Italy, 24% see time to pricing occur between 1-2 years after approval.
